Inventor · disambiguated record
Cy Stein
Also filed as: STEIN CY · STEIN CY A · STEIN CY AARON
17 granted patents·8 pending applications·4,803 citations·filing 1988–2023
95Inventor score
Top patents by PatentIndex Score
25 records- 0196US5286717AInhibitors for replication of retroviruses and for the expression of oncogene productsUS HEALTH·Filed 1992·Granted Feb 15, 1994·1.4k cites·20 claims
- 0296US5276019AInhibitors for replication of retroviruses and for the expression of oncogene productsUS HEALTH·Filed 1988·Granted Jan 4, 1994·1.5k cites·43 claims
- 0394US5264423AInhibitors for replication of retroviruses and for the expression of oncogene productsUS HEALTH·Filed 1992·Granted Nov 23, 1993·1.5k cites·48 claims
- 0492US5756710APhosphorothioate oligonucleotides that bind to the V3-loop and uses thereofUNIV COLUMBIA·Filed 1996·Granted May 26, 1998·147 cites·13 claims
- 0585US9156878B2Treatment of prostate cancerTOKAI PHARMACEUTICALS INC·Filed 2014·Granted Oct 13, 2015·8 cites·11 claims
- 0685US6030955AMethods of affecting intracellular phosphorylation of tyrosine using phosphorothioate oligonucleotides, and antiangiogenic and antiproliferative uses thereofUNIV COLUMBIA·Filed 1996·Granted Feb 29, 2000·76 cites·3 claims
- 0782US7074769B2Oligonucleotide inhibitors of bcl-xLARONEX PHARMACEUTICALS INC·Filed 2001·Granted Jul 11, 2006·16 cites·3 claims
- 0880US8791094B2Treatment of prostate cancerMORRISON JODIE POPE·Filed 2010·Granted Jul 29, 2014·7 cites·26 claims
- 0975US5545626AMethod of treating glaucoma with oligonucleotidesUNIV COLUMBIA·Filed 1994·Granted Aug 13, 1996·45 cites·22 claims
- 1073US2023340480A1Methods for intracellular delivery and enhanced gene targetingHOPE CITY·Filed 2023·Application pending·0 cites
- 1169US5158940AUse of suramin to treat rheumatologic diseasesUS HEALTH·Filed 1990·Granted Oct 27, 1992·24 cites·11 claims
- 1260US11643655B2Methods for intracellular delivery and enhanced gene targetingHOPE CITY·Filed 2017·Granted May 9, 2023·0 cites·13 claims
- 1356US2017157148A1Treatment of prostate cancerTOKAI PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 1455US6770753B2Phosphorothioate antisense heparanase oligonucleotidesUNIV COLUMBIA·Filed 2001·Granted Aug 3, 2004·0 cites·11 claims
- 1551US2005065103A1Phosphorothioate antisense heparanase oligonucleotidesFiled 2002·Application pending·0 cites
- 1650US2015203528A1Treatment of prostate cancerTOKAI PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 1750US2015166599A1Treatment of prostate cancerTOKAI PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 1849US5173509ASuramin and active analogues thereof in the treatment of hypercalcemiaUS HEALTH·Filed 1990·Granted Dec 22, 1992·15 cites·3 claims
- 1948US6867043B2Peptides that deliver antisense oligonucleotides which downregulate protein expression in cellsUNIV COLUMBIA·Filed 2001·Granted Mar 15, 2005·0 cites·26 claims
- 2045US2002098231A1Oligonucleotide inhibitors of bcl-xLUNIV COLUMBIA·Filed 2001·Application pending·0 cites
- 2142US2003211583A1Egs molecules that specifically downregulae bcl-xl experessionFiled 2001·Application pending·0 cites
- 2241US11759530B2TKI permeability enhancersHOPE CITY·Filed 2015·Granted Sep 19, 2023·0 cites·5 claims
- 2341US2005261225A1Peptides that deliver antisense oligonucleotides which downregulate protein expression in cellsUNIV COLUMBIA·Filed 2005·Application pending·0 cites
- 2437US5854223AS-DC28 as an antirestenosis agent after balloon injuryUNIV COLUMBIA·Filed 1996·Granted Dec 29, 1998·7 cites·15 claims
- 2528US5792657ASteroid secreting human adrenocortical carcinoma cell linesUS ARMY·Filed 1995·Granted Aug 11, 1998·1 cites·1 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →